Publication | Open Access

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study

Retrospective StudyType 1Cancer ImmunosurveillanceMedicineDiabetesImmunologyMelanomaMetastatic MelanomaImmune Checkpoint InhibitorImmunotherapyOncologyRadiation Oncology